This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Will Salesforce.com (CRM) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Salesforce.com (CRM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights Walmart, Alibaba Group Holding, Salesforce, HCA Healthcare and MetLife
by Zacks Equity Research
Walmart, Alibaba Group Holding, Salesforce, HCA Healthcare and MetLife are included in this Analyst Blog.
Top Research Reports for Walmart, Alibaba & Salesforce
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc. (WMT), Alibaba Group Holding Limited (BABA) and Salesforce, Inc. (CRM).
Earnings Estimates Rising for Salesforce.com (CRM): Will It Gain?
by Zacks Equity Research
Salesforce.com (CRM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Salesforce Inc. (CRM) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Salesforce.com (CRM). This makes it worthwhile to examine what the stock has in store.
Salesforce.com (CRM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Salesforce.com (CRM) closed at $164.75, marking a +0.14% move from the previous day.
Salesforce.com (CRM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Salesforce.com (CRM) closed the most recent trading day at $154.86, moving -0.65% from the previous trading session.
Company News for Jan 24, 2023
by Zacks Equity Research
Companies in The News Are: BKR,NWBI,TSLA,CRM
Zacks Investment Ideas feature highlights: Jabil Inc., Salesforce and NetEase
by Zacks Equity Research
Jabil Inc., Salesforce and NetEase are part of the Zacks Investment Ideas article.
Salesforce.com (CRM) Surges 3.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
Salesforce.com (CRM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
These 3 Tech Stocks Are Already up 15% In 2023
by Derek Lewis
With sentiment slowly shifting following better-than-expected inflation data over the last several weeks, buyers have finally returned to the Technology sector after a long hibernation. Can the hot start continue?
If You Invested $1000 in Salesforce.com a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Salesforce (CRM) Stake Reportedly Bought by Elliot Investment
by Zacks Equity Research
Elliot Investment's stake buyout in Salesforce (CRM) is expected to increase pressure on the business software maker's management to make operational improvements and increase profit margins.
Investors Heavily Search Salesforce Inc. (CRM): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Salesforce.com (CRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks Investment Ideas feature highlights: IGV, Salesforce, Okta, Palo Alto Networks and Hello Group
by Zacks Equity Research
IGV, Salesforce, Okta, Palo Alto Networks and Hello Group are part of the Zacks Investment Ideas article.
Salesforce.com (CRM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Salesforce.com (CRM) closed at $148.47, marking a -0.7% move from the previous day.
Software is Still "Eating the World": 3 Top-Ranked Stocks to Keep on Your Radar
by Andrew Rocco
Software has had a rough couple of years. However, Andrew Rocco will discuss how crisis may lead to opportunity in this struggling industry.
The Zacks Analyst Blog Highlights JPMorgan Chase, Chevron, Salesforce, CVS Health and FedEx
by Zacks Equity Research
JPMorgan Chase, Chevron, Salesforce, CVS Health and FedEx are included in this Analyst Blog.
Salesforce.com (CRM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Salesforce.com (CRM) closed the most recent trading day at $144.90, moving -1.72% from the previous trading session.
Top Research Reports for JPMorgan Chase, Chevron & Salesforce
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Chevron Corporation (CVX) and Salesforce, Inc. (CRM).
Why Is Oracle (ORCL) Up 7.4% Since Last Earnings Report?
by Zacks Equity Research
Oracle (ORCL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Invest in the iShares Expanded TechSoftware Sector ETF (IGV)?
by Zacks Equity Research
Sector ETF report for IGV
Is Salesforce (CRM) Stock Outpacing Its Computer and Technology Peers This Year?
by Zacks Equity Research
Here is how Salesforce.com (CRM) and DecisionPoint Systems Inc. (DPSI) have performed compared to their sector so far this year.
Here is What to Know Beyond Why Salesforce Inc. (CRM) is a Trending Stock
by Zacks Equity Research
Salesforce.com (CRM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Dow Likely to Continue Outperforming Peers in 2023: 5 Picks
by Nalak Das
We have narrowed our search to five Dow stocks. These are: NKE, PG, CRM, IBM and CAT.